Abstract
OBJECTIVE:
To review the evidence that taurine can prevent cholestasis in neonates.
DATA SOURCES:
MEDLINE and EMBASE searches were conducted to identify both animal and human data regarding taurine's role in bile acid conjugation and liver disease (key terms: taurine, children less than two years old).
STUDY SELECTION:
Emphasis was placed on human data supplemented by relevant animal data.
DATA SYNTHESIS:
Taurine appears to more effectively conjugate bile acids than glycine, and the end-products of conjugation are more soluble. Taurine deficiency may increase glyco-conjugates of bile acids and result in cholestasis. Although the cause of neonatal cholestasis probably is multifactorial, there are data indicating that adequate taurine may prevent cholestasis in neonates.
CONCLUSIONS:
Taurine should be considered an essential amino acid for neonates and should be included in total parenteral nutrition solutions for these patients.
Get full access to this article
View all access options for this article.
